Isoform-specific functions of phosphoinositide 3-kinases:: p110δ but not p110γ promotes optimal allergic responses in vivo

被引:104
作者
Ali, Khaled [1 ]
Camps, Montserrat [2 ]
Pearce, Wayne P. [1 ]
Ji, Hong [2 ]
Rueckle, Thomas [2 ]
Kuehn, Nicolas [3 ]
Pasquali, Christian [2 ]
Chabert, Christian [2 ]
Rommel, Christian [2 ]
Vanhaesebroeck, Bart [1 ]
机构
[1] Queen Mary Univ London, Sir John Vane Res Ctr, Inst Canc, Ctr Cell Signaling, London EC1M 6BQ, England
[2] Merck Serono Int, Geneva Res Ctr, Geneva, Switzerland
[3] Frimorfo, Fribourg, Switzerland
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.4049/jimmunol.180.4.2538
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The leukocyte-enriched p110 gamma and p110 delta isoforms of PI3K have been shown to control in vitro degranulation of mast cells induced by cross-linking of the high affinity receptor of IgE (Fc epsilon RI). However, the relative contribution of these PI3K isoforms in IgE-dependent allergic responses in vivo is controversial. A side-by-side comparative analysis of the role of p110 gamma and p110 delta in mast cell function, using genetic approaches and newly developed isoform-selective pharmacologic inhibitors, confirms that both PI3K isoforms play an important role in Fc epsilon RI-activated mast cell degranulation in vitro. In vivo, however, only p110 delta was found to be required for optimal IgE/Ag-dependent hypersensitivity responses in mice. These observations identify p110 delta as a key therapeutic target among PI3K isoforms for allergy- and mast cell-related diseases.
引用
收藏
页码:2538 / 2544
页数:7
相关论文
共 38 条
[1]   Essential role for the p110δ phosphoinositide 3-kinase in the allergic response [J].
Ali, K ;
Bilancio, A ;
Thomas, M ;
Pearce, W ;
Gilfillan, AM ;
Tkaczyk, C ;
Kuehn, N ;
Gray, A ;
Giddings, J ;
Peskett, E ;
Fox, R ;
Bruce, I ;
Walker, C ;
Sawyer, C ;
Okkenhaug, K ;
Finan, P ;
Vanhaesebroeck, B .
NATURE, 2004, 431 (7011) :1007-1011
[2]   Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Wynshaw-Boris, A ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10963-10968
[3]   Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Nussbaum, RL .
MAMMALIAN GENOME, 2002, 13 (03) :169-172
[4]   Key role of the p110δ isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling:: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells [J].
Bilancio, A ;
Okkenhaug, K ;
Camps, M ;
Emery, JL ;
Ruckle, T ;
Rommel, C ;
Vanhaesebroeck, B .
BLOOD, 2006, 107 (02) :642-650
[5]   The ins and outs of IgE-dependent mast-cell exocytosis [J].
Blank, U ;
Rivera, J .
TRENDS IN IMMUNOLOGY, 2004, 25 (05) :266-273
[6]  
Boyce JA, 2004, ALLERGY ASTHMA PROC, V25, P27
[7]   Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis [J].
Camps, M ;
Rückle, T ;
Ji, H ;
Ardissone, V ;
Rintelen, F ;
Shaw, J ;
Ferrandi, C ;
Chabert, C ;
Gillieron, C ;
Françon, B ;
Martin, T ;
Gretener, D ;
Perrin, D ;
Leroy, D ;
Vitte, PA ;
Hirsch, E ;
Wymann, MP ;
Cirillo, R ;
Schwarz, MK ;
Rommel, C .
NATURE MEDICINE, 2005, 11 (09) :936-943
[8]   p110 delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes [J].
Chantry, D ;
Vojtek, A ;
Kashishian, A ;
Holtzman, DA ;
Wood, C ;
Gray, PW ;
Cooper, JA ;
Hoekstra, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) :19236-19241
[9]   Phosphoinositide 3-kinase: Diverse roles in immune cell activation [J].
Deane, JA ;
Fruman, DA .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :563-598
[10]   Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation [J].
Foukas, LC ;
Claret, M ;
Pearce, W ;
Okkenhaug, K ;
Meek, S ;
Peskett, E ;
Sancho, S ;
Smith, AJH ;
Withers, DJ ;
Vanhaesebroeck, B .
NATURE, 2006, 441 (7091) :366-370